Skip to main navigation Skip to search Skip to main content

Fox Chase Cancer Center Home

Help & FAQ Link opens in a new tab

Search content at Fox Chase Cancer Center

Home
Profiles
Research Units
Research Resources
Research Outputs
Prizes
Activities
Press/Media

A new strategy to ERADicate HER2-positive breast tumors?

Sanjeevani Arora
, Erica A. Golemis

Cancer Epigenetics Institute
Cancer Prevention and Control (CPC)
Cancer Research Training and Education
Cancer Signaling and Microenvironment (CSM)
Greenberg Pancreatic Cancer Institute

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Overview
Fingerprint

Fingerprint

Dive into the research topics of 'A new strategy to ERADicate HER2-positive breast tumors?'. Together they form a unique fingerprint.

Sort by

Weight
Alphabetically

Neuroscience

Medicine and Dentistry

Powered by Pure Link opens in a new tab, Scopus Link opens in a new tab & Elsevier Fingerprint Engine™ Link opens in a new tab

All content on this site: Copyright © 2026 Fox Chase Cancer Center, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

This site uses Google Analytics to obtain site usage information such as users IP addresses, Internet domain and host names, browser software, and the date and time the site is visited. The data collection is restricted by the Google Analytics Terms of Service and the Google Privacy Policy.

Fox Chase Cancer Center data protection policy Link opens in a new tab

About web accessibility Link opens in a new tab

Report vulnerability Link opens in a new tab